How GLP-1 Drugs Are Changing Restaurant Check Averages (2026)

Restaurant server taking a guest order — 1 in 8 U.S. adults is now on a GLP-1 drug like Ozempic, structurally changing how restaurant guests eat and spend
Restaurant Business · Industry Analysis

How GLP-1 Drugs Are Changing Restaurant Check Averages

GLP-1 users consume 21% fewer calories and spend nearly a third less on food. Here's what Ozempic and similar drugs are doing to restaurant check averages, which menu categories are most exposed, and what operators should do about it.

12 min read ~2,800 words Industry analysis, May 2026
1 in 8 U.S. adults now taking a GLP-1 appetite-suppressing drug CNBC / Amelia Lucas, March 2026
21% fewer calories consumed by GLP-1 users on average Circana, November 2025
$55B projected annual food & beverage revenue reduction by 2030–2034 J.P. Morgan Global Research, February 2026

A Structural Shift, Not a Diet Trend

Every few years, a new diet trend moves through the restaurant industry. Low-carb orders spike. Gluten-free requests multiply. Plant-based add-ons appear on menus. Operators adapt at the margins, sales settle, and the cycle continues.

GLP-1 medications are different. They don't change what people want to eat — they suppress the neurological drive to eat in the first place. When appetite itself is pharmaceutical, the downstream effects on food spending are not a matter of preference. They're physiological.

According to Circana research cited by Ankura Consulting's April 2026 restaurant sector report, 23% of U.S. households now contain at least one GLP-1 user. That's not a niche population. That's a meaningful share of the dining public — one that orders less, spends less per visit, and gravitates toward a fundamentally different set of menu categories than the general population.

23%
of U.S. households contain at least one GLP-1 user — meaning that nearly one in four tables you seat may include someone whose appetite is being actively suppressed by medication. The behavioral effects don't stay at home. Circana, November 2025
Guests dining at a restaurant — GLP-1 weight-loss drugs are changing eating behavior for a growing share of the dining public, with structural implications for restaurant operators

The question for restaurant operators is no longer whether GLP-1 is worth paying attention to. The user base is already large enough that it shapes check averages, category mix, and menu performance in measurable ways. The question is how to read those signals accurately — and how to respond before competitors do.

How Many People Are on GLP-1 Drugs — and Where It's Headed

GLP-1 receptor agonists — originally developed to manage type 2 diabetes — became a mainstream weight-loss category after Ozempic's consumer breakthrough in 2023. Wegovy, Mounjaro, and Zepbound followed. By early 2026, the category has moved well past early adopters into broad consumer use.

GLP-1 Adoption: Current Scale & Projections
Current U.S. users
~10 million
Projected 2030 users
25–30 million
Households affected
23%
Global market by 2030
$200B
U.S. GLP-1 user growth trajectory (millions)
Sources: J.P. Morgan Global Research, Feb 2026; Circana, Nov 2025. 2030 range midpoint used for projection bar.

J.P. Morgan's February 2026 analysis projects the U.S. GLP-1 user base growing from approximately 10 million today to between 25 and 30 million by 2030 — a 2.5x to 3x increase. The global market is expected to reach $200 billion over the same period, driven by expanding insurance coverage, biosimilar competition lowering costs, and new oral formulations removing the injection barrier for many potential users.

For restaurant operators, the relevant number isn't the absolute user count — it's the household penetration figure. At 23% of households already containing at least one user, GLP-1 is no longer a behavioral edge case. It's a dining-room reality.

Key Takeaway

The GLP-1 user base is growing 2–3x by 2030, but it's already large enough to show up in your sales data right now. If your check averages have softened without an obvious explanation, user mix is worth investigating before you blame the economy or the competition.

How GLP-1 Users Eat and Spend Differently

The behavioral data on GLP-1 users is now consistent enough to draw clear conclusions. They are not simply "lighter eaters" — their food consumption and spending patterns differ from the general population in specific, measurable ways that translate directly to restaurant economics.

Calorie reduction 21% fewer calories consumed on average
GLP-1 users consume significantly less at each meal. Portion sizes shrink. Add-ons and extras — appetizers, desserts, large-format beverages — are the first things to go.
Grocery spend ~33% less spent on food overall
GLP-1 users spend nearly one-third less on food overall, a decline that spans grocery and foodservice. Lower food spend per visit means lower average checks when GLP-1 users dine out.
Category shift Toward protein away from snacks and sweets
GLP-1 users gravitate toward high-protein, nutrient-dense options and away from snacks, sweets, baked goods, and large-format sugary beverages — the exact categories with the highest margins for most operators.

The check-size implication is the most direct near-term concern. When a GLP-1 user orders a single entrée instead of an entrée plus appetizer, skip the dessert, and declines a second drink, the ticket shrinks without any visible signal to the operator. There's no complaint, no negative review — just a structurally lower average check from a portion of your dining room.

"GLP-1 users are not eating out less. They are spending less per occasion — and ordering differently every time."

Circana research, November 2025 (via Ankura Restaurant Sector Report, April 2026)

The higher-protein orientation is the flip side of the same behavioral shift. GLP-1 suppresses appetite broadly, but users who are eating less tend to prioritize nutrient density when they do eat. Protein-forward dishes — grilled proteins, whole foods, grain bowls — over-index among this group. High-sugar, high-fat indulgence items under-index.

The Revenue Math: $30–55 Billion at Stake

The aggregate numbers are stark. J.P. Morgan's February 2026 global research report projects a $30–55 billion annual revenue reduction for the food and beverage industry by 2030–2034, attributable directly to GLP-1 adoption. Circana projects that GLP-1 households will account for 35% of all food and beverage units sold by 2030 — a share large enough to reshape category economics at the manufacturer and foodservice level simultaneously.

35%
of all U.S. food and beverage units sold by 2030 will come from GLP-1 households — at which point their collective preferences are not a niche to accommodate. They are a primary market to design for. Circana, November 2025

For individual operators, the translation from macro projections to P&L impact depends on concept type, location, and customer mix. A family-casual chain with a dessert program built around high-margin sundae upsells faces a different exposure profile than a fast-casual protein bowl operator. But the directional pressure is consistent across the board: the eating behaviors that generated add-on revenue in the prior decade are in structural decline.

Where the revenue pressure actually shows up

For restaurant operators, GLP-1's revenue impact doesn't typically arrive as a headline decline in traffic. It shows up in three more subtle places:

1
Softening average check Fewer add-ons, smaller portions, less dessert. The same table generates less revenue per visit with no change in cover count or traffic. If your average check has drifted down without a clear price or mix explanation, GLP-1 user behavior is a candidate driver worth isolating.
2
Category mix erosion High-margin categories — desserts, appetizers, large-format beverages, snack-style sides — face the most structural pressure. If your dessert attach rate or appetizer pull-through has slipped, the explanation may not be menu quality or pricing. It may be a behavioral shift in who's sitting at your tables.
3
Occasion erosion in high-indulgence dayparts Late-night, dessert-forward, and snack occasions are more sensitive to appetite suppression than meal-replacement occasions. If specific dayparts have softened without competitive or macro explanations, the GLP-1 population's reduced appetite at non-meal times is worth examining.

Which Menu Categories Face the Most Risk

Research published in the Journal of Marketing Research (Hristakeva, Liaukonyte, and Feler, December 2024) provides the most granular category-level data on GLP-1's food demand effects. Savory snacks face the steepest projected decline at approximately -10%, with the researchers noting similar large decreases in sweets, baked goods, and cookies.

Menu categoryGLP-1 exposureWhyOperator implication
Appetizers & shareable snacks High Appetite suppression hits before-meal grazing hardest. GLP-1 users often skip starters entirely. Attach rates likely declining. Investigate whether add-on prompting strategy needs revision.
Desserts & baked goods High Research shows "similar large decreases" to snacks. High-calorie indulgence occasions are the most suppressed. Dessert program size and investment should be pressure-tested against current sales data.
Large-format & sugary beverages High Sweetened beverages are a snack-adjacent category that GLP-1 users consistently reduce. Alcohol and soft drink attach on tables with GLP-1 users may be running below historical norms.
Entrées — standard portions Medium Meal occasions are more durable than snack occasions, but portion completion rates may fall. Takeaway containers and portion-size optionality matter more with this guest population.
High-protein entrées Low / Opportunity GLP-1 users over-index toward protein-dense foods. Grilled proteins, bowls, lean formats perform well. Explicit protein content callouts and high-protein menu sections have growing relevance.
Nutrient-dense / whole foods Low / Opportunity Users optimizing for satiety with fewer calories gravitate toward nutrient-dense options. Grain bowls, salads with protein, whole-ingredient dishes are where GLP-1 demand concentrates.
Reading your own data
  • Pull your appetizer, dessert, and beverage attach rates for the last 12 months and trend them monthly. A gradual decline without a price change or competitive event is the signature of a behavioral shift, not a menu problem.
  • Look at your highest-margin items specifically — not overall revenue. GLP-1 behavioral shifts tend to affect margin mix before they affect total revenue, which is why they're easy to miss until the margin pressure is already entrenched.
  • If your POS allows segmentation by table size or visit frequency, look at whether regular guests are running lower checks than they did 12–18 months ago. Repeat guests are the cohort most likely to include GLP-1 users.

How Major Chains Are Already Responding

The national chains that have moved first on GLP-1 adaptation share a common strategic logic: protein-forward positioning, portion optionality, and explicit callouts of nutrient density. The moves are visible across quick service, fast casual, and coffee segments.

BrandSegmentAdaptationLogic
Chipotle Fast casual Launched dedicated "High Protein Menu" with additional protein options across bowls and burritos Explicitly targets the protein-prioritizing GLP-1 user; positions Chipotle as a GLP-1-friendly default
Starbucks Coffee / QSR Built protein into approximately 90% of drink offerings, per Axios March 2026 reporting Repositions beverage occasions as nutritionally substantive rather than purely indulgent
Shake Shack Fast casual Introduced protein-dense, portion-controlled menu items Retains GLP-1 users who might otherwise reduce visit frequency due to smaller appetite
Subway QSR Introduced protein-dense, portion-controlled options alongside existing customization Extends existing "build your own" model to explicitly serve smaller-appetite occasions
Brinker / Maggiano's Casual dining Boosted pasta portions by ~20%, expanded Family Style menu — no price increases Counter-positioning: bets that abundance and generosity differentiates in an era of shrinking portions elsewhere

Brinker's counter-move with Maggiano's is worth noting because it illustrates that GLP-1 adaptation isn't monolithic. Not every concept should pivot toward smaller portions and protein callouts. Maggiano's is explicitly positioning around the occasion where abundance is the point — family-style Italian, celebration dining, shared plates. That occasion is less sensitive to GLP-1 behavior because it's not built around individual portion consumption.

The implication for independent operators: the right response depends on your concept's occasion type, not a generic adjustment to the trend.

A restaurant kitchen prepping high-protein dishes — major chains including Chipotle and Starbucks are restructuring menus to capture GLP-1 users who prioritize protein-dense, nutrient-forward options

The Retention Wildcard: Why the User Base Is Never Static

GLP-1 adoption comes with a complication that makes forecasting difficult: the dropout rate is remarkably high. An estimated 50–75% of users discontinue within their first year, according to research cited by Northwestern University in November 2024.

50–75%
of GLP-1 users discontinue within one year — a churn rate that means the active user population is constantly cycling. Behavioral habits formed on-drug may partially persist after discontinuation, but the population making active dietary choices based on pharmaceutical appetite suppression is always in flux. Northwestern Now, November 2024

This creates a layered picture. The user base is simultaneously growing in absolute terms (new adopters coming in as costs fall and access expands) and cycling at high rates (a majority discontinuing within 12 months). The behavioral imprint left after discontinuation is not well-documented — some research suggests that eating habits formed on-drug partially persist, but this isn't conclusive.

For operators, the practical implication is that GLP-1 user behavior shouldn't be read as a permanent, static feature of your dining room. It's a dynamic, growing population with high individual churn. What this means in practice:

  • Don't over-rotate your entire menu. Today's GLP-1 users are 1 in 8 adults. Tomorrow's may be 1 in 4 — but half of today's active users will have stopped by next year. Menu adaptation should expand your range, not eliminate what works for the rest of your guests.
  • Track behavioral trends, not individual guests. The relevant data is aggregate category performance and check trends, not attempting to identify GLP-1 users in your dining room. Read the signals at the menu and daypart level.
  • Plan for a growing baseline, not a plateau. Even with high discontinuation rates, the net user population is on a clear growth trajectory. J.P. Morgan's 2.5–3x growth projection to 2030 accounts for dropout. The trend is larger-user-base, not smaller.

"The GLP-1 user base is growing, churning, and growing again — operators who track the behavior rather than the population will make better decisions."

Synthesis — Ankura Consulting / J.P. Morgan / Northwestern Now, 2024–2026

What Independent Operators Should Do Now

The chains adapting to GLP-1 have full analytics teams, national POS data, and product development cycles measured in months. Independent operators have something the chains don't: proximity to their guests and the ability to move faster. The playbook doesn't require a brand overhaul — it requires reading your own data and making targeted adjustments.

Start with a menu exposure audit

Before changing anything, understand where your revenue is concentrated and which of those categories has the highest GLP-1 sensitivity. The risk isn't spread evenly across your menu.

Question to answerWhere to find the dataWhat you're looking for
What % of revenue comes from appetizers, desserts, and non-alcoholic beverages? POS category mix report, last 12 months Higher exposure if these combined categories exceed 25–30% of food revenue
Has average check per cover changed in the last 12–18 months? POS average check trend, same-period comparison A sustained 3–5% decline without a price reduction or menu change is a signal worth investigating
Have dessert and appetizer attach rates changed? POS add-on attach by category Declining attach without competitive or seasonal explanation indicates behavioral shift
What protein options are on your menu and how are they performing? POS item-level sales mix If protein-forward items are gaining share relative to heavier indulgence items, the behavioral shift is already visible

Three adaptations that don't require a full menu overhaul

1
Add protein callouts to existing high-performing dishes You don't need to create new menu items. Identify your existing dishes that are already protein-dense — grilled proteins, grain-based bowls, lean mains — and flag them explicitly on the menu. "High protein" or protein gram counts are increasingly being used by chains and perform well with GLP-1 users at zero cost to the kitchen.
2
Introduce smaller-portion optionality on high-margin items Rather than eliminating your dessert program or large-format items, offer a half-portion or "tasting" format. GLP-1 users don't skip dessert because they dislike it — they skip it because a full portion is physiologically too much. A smaller-format option maintains the attachment and retains some of the margin.
3
Revisit your beverage program's non-alcoholic offering Non-alcoholic beverages are a category where GLP-1 users actively seek alternatives to sugary drinks but remain willing to spend if the options are substantive — protein shakes, functional beverages, premium sparkling waters with flavor. Starbucks' pivot to protein in 90% of offerings is an indication of where this category is going.

What the seating and layout data tells you

There's a secondary implication of the GLP-1 shift that operators tend to overlook: if portions are getting smaller and diners are ordering less, table turn time may actually decrease. Guests who eat less finish faster. In environments where covers per night are a primary revenue driver, this could work in your favor — but only if your floor plan and seating configuration are optimized for efficient turn and guest comfort at shorter dwell times.

The operators seeing the most benefit from this dynamic are those with layouts designed for throughput — well-spaced tables that don't create bottlenecks, seating that's comfortable for a 45-minute meal rather than one requiring a two-hour anchor. If you're evaluating a layout refresh, understanding how seating configuration affects covers per night is the right framework to apply.

Restaurant operator reviewing menu data and financial reports — understanding GLP-1's impact on category mix and check averages requires looking at POS data at the item and daypart level
Key Takeaway

The right response to GLP-1 is not a menu reinvention. It's a targeted expansion of what your menu offers, calibrated to where your specific revenue exposure sits. Read your own data first. Adapt from evidence, not trend anxiety.

The longer-term arc: where this ends up by 2030

2026 (now) 1 in 8 adults on GLP-1 drugs. 23% household penetration. Behavioral signals visible in POS data for operators paying attention. Chain response underway — Chipotle, Starbucks, Shake Shack, Subway already adapted. Most independents still in wait-and-see mode.
2027–2028 Oral GLP-1 formulations (eliminating injection barrier) expected to accelerate adoption. Cost pressure from biosimilar competition broadens access beyond high-income early adopters. User base likely crosses 15–18 million. Operators who haven't audited their menu exposure will begin seeing it in quarterly results.
2029–2030 J.P. Morgan's 25–30 million U.S. user projection. GLP-1 households representing 35% of all food and beverage units sold. A $30–55 billion annual revenue reduction materializes across the food and beverage industry. Operators who adapted early will have structural advantages in their protein-forward and portion-flexible menu positioning.

Understanding your restaurant's operating cost baseline?

Pair this analysis with our full 50-state breakdown of restaurant operating costs — labor, rent, utilities, and taxes modeled for every state.

See the Cost Index

Frequently Asked Questions

How are GLP-1 drugs affecting restaurants?
+
GLP-1 users consume an estimated 21% fewer calories and spend roughly a third less on food overall. For restaurants, this means smaller average checks from GLP-1 users, potential declines in high-margin add-on categories like desserts and snacks, and a structural shift in demand toward high-protein, portion-controlled menu items. J.P. Morgan projects a $30–55 billion annual revenue reduction for the broader food and beverage industry by 2030–2034.
How many people are on GLP-1 drugs like Ozempic?
+
As of early 2026, approximately one in eight U.S. adults is taking a GLP-1 appetite-suppressing drug like Ozempic, Wegovy, or Mounjaro. About 23% of U.S. households contain at least one GLP-1 user. J.P. Morgan projects U.S. users will grow from approximately 10 million today to 25–30 million by 2030, with the global GLP-1 market reaching $200 billion.
Which restaurant categories are most at risk from GLP-1 adoption?
+
Research from the Journal of Marketing Research found savory snacks face the steepest projected decline at approximately -10%, with similar large decreases projected for sweets, baked goods, cookies, and sugary beverages. Menu categories built around indulgence, large portions, or snacking occasions carry the highest near-term exposure. High-protein, nutrient-dense, and portion-controlled options are the highest-demand categories among GLP-1 users.
Are GLP-1 users eating out less?
+
GLP-1 users are not necessarily eating out less — but they are ordering differently and spending less per visit. They consume an estimated 21% fewer calories and spend roughly one-third less on food overall. The impact on restaurant revenue shows up through smaller average check sizes, fewer add-ons, and reduced frequency in high-indulgence dining occasions rather than a wholesale exit from restaurant dining.
What are restaurant chains doing to adapt to GLP-1 users?
+
Major chains are pivoting toward protein-forward menus and portion-controlled options. Chipotle launched its High Protein Menu with additional protein options. Starbucks has incorporated protein into nearly 90% of its drink offerings. Shake Shack and Subway have introduced protein-dense, portion-controlled menu items. On the packaged side, Nestlé and General Mills have reformulated products specifically targeting GLP-1 users. Not all chains are following the same playbook — Brinker's Maggiano's has moved in the opposite direction, expanding portions to position around abundance as a differentiator.
Is the GLP-1 restaurant trend permanent?
+
GLP-1 adoption is a structural shift, but it comes with an important wildcard: an estimated 50–75% of users discontinue within a year. The user base is simultaneously growing (from 10 million toward 25–30 million by 2030) and cycling through — meaning some behavioral changes may persist even after discontinuation, but the active user population is never static. The long-run trajectory is toward a significantly larger user base as costs fall and access expands through oral formulations and biosimilar competition.